Innovative Health

06/12/2026

When an electrophysiology lab uses reprocessed sensor-enabled catheters in an AFib ablation procedure, it can reduce procedure costs by thousands of dollars - and reduce environmental harm. The carbon emission footprint of a reprocessed sensor-enabled catheter is approximately 50% of the carbon emission footprint of a new device. Innovative Health’s recent whitepaper, Reprocessing Sensor-Enabled Mapping Catheters, describes in scientific detail how sensor-enabled catheters are reprocessed: https://na2.hubs.ly/H066ntd0

06/04/2026

Until recent legal action enabled the extended use of reprocessed sensor-enabled catheters in these procedures, the use of these in AFib procedures was limited due to original manufacturer interference. Innovative Health’s recent whitepaper, Reprocessing Sensor-Enabled Mapping Catheters, describes in scientific detail how sensor-enabled catheters are reprocessed and how substantially equivalent performance is ensured: https://na2.hubs.ly/H05Dcl60

05/28/2026

Innovative Health’s recent whitepaper, Reprocessing Sensor-Enabled Mapping Catheters, describes in scientific detail how sensor-enabled catheters are reprocessed and how substantially equivalent performance is ensured while the environmental impact is reduced: https://na2.hubs.ly/H05DdbP0

05/21/2026

When an electrophysiology lab uses reprocessed sensor-enabled catheters in an AFib ablation procedure, it can reduce procedure costs by thousands of dollars – money that can be critical to hospital profitability and its ability to extend the proper care to as many patients as possible – while environmental harm is reduced. See Innovative Health’s latest whitepaper: https://na2.hubs.ly/H05Dc3b0

05/19/2026

What Is Missing from Our Discussion About Reprocessing and Healthcare Sustainability?

AMDR, as a trade association, demands higher standards from its members than those formally imposed on the industry by regulation.

05/14/2026

While US pharmaceutical, medical device, and health insurance companies have no problem making money, it is different for hospitals. Decreasing reimbursement, increasing costs, and the shift to outpatient care sites squeeze operating margins and limit profit pool growth. The average hospital in the U.S. in August last year had a 1% operating margin. Over the past 15 years, more hospitals have closed than opened. Last year alone, there were at least 23 reported hospital closures or planned closures in the United States. Hospital layoffs are at record highs. Watch Innovative Health CEO Rick Ferreira discuss the Heart Rhythm Society conference in this short video: https://na2.hubs.ly/H05rzKf0

05/07/2026

Monopolies are unhealthy for American healthcare. In electrophysiology, they are a serious threat to the ability of the electrophysiologist to choose the technology he or she wants to use. For hospitals, monopolies mean higher costs. Watch Innovative Health CEO Rick Ferreira discuss the Heart Rhythm Society conference in this short video: https://na2.hubs.ly/H05l2yb0

04/30/2026

Times are tough for U.S. hospitals. Prices keep going up, but reimbursement does not. As a result, insurance companies make more money, healthcare technology companies make more money, and pharmaceutical companies make more money. Only the provider loses: The average hospital in the U.S. in August last year had a 1% operating margin. Hospital closures have reached record levels. And who loses when the provider loses: The patient. With the kind of market concentration we see in electrophysiology, two things happen: Providers (hospitals and doctors) have less and less real choice over what they buy—and prices go up. Watch Innovative Health CEO Rick Ferreira discuss the Heart Rhythm Society conference in this short video: https://na2.hubs.ly/H05cYPk0

04/23/2026

This year, electrophysiologists meet in Chicago, April 23 to 26 - at the 2026 Heart Rhythm Society conference. Every year, there are new technologies for the doctors to peruse. As a result, doctors always have new technology available to them, so that patients can get the best treatment possible. This sounds like a great win-win situation. However, there is a dangerous imbalance in the market, where few suppliers of medical technology act as monopolists that deprive hospitals of financial control and physicians of real choice. Watch Innovative Health CEO Rick Ferreira discuss HRS in this short video: https://na2.hubs.ly/H052fLW0

04/21/2026

Supply Chain Resilience is Bigger than the Purchasing Department

Supply Chain Resilience is Bigger than the Purchasing Department